Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
February 14, 2022
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma
David M Routman, Sunil Kumar, Bisham S Chera, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 28, 2020
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx
Mark R Waddle, Daniel J Ma, Sue L Visscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2019
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma
Daniel J Ma, Katharine A Price, Eric J Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2019
Reply to A.S. Garden
Daniel J Ma, Katharine A Price, Eric J Moore, et al.
Journal for Immunotherapy of Cancer
|
April 15, 2025
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial
Matthew S Block, Garth D Nelson, Jun Chen, et al.
Nature Communications
|
February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Tina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
May 22, 2025
ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial
David M Routman, Kathryn M Van Abel, Katharine A Price, et al.
Oral Oncology
|
September 21, 2023
Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center
Chadi N Abdel-Halim, Thomas J O'Byrne, Jeffrey P Graves, et al.
Oral Oncology
|
May 18, 2025
Identification of clinical and pathologic features associated with extranodal extension in patients with HPV-mediated oropharyngeal squamous cell carcinoma
Brennan Olson, Aaron Bogan, Chadi N Abdel-Halim, et al.
JAMA Network Open
|
May 18, 2026
De-Escalated Adjuvant Radiation Therapy in Patients With HPV-Positive Oropharyngeal Cancer
Cecelia M Hidalgo, Aaron W Bogan, Katelyn S Rourk, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
International Journal of Radiation Oncology, Biology, Physics
|
February 14, 2022
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma
David M Routman, Sunil Kumar, Bisham S Chera, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 28, 2020
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx
Mark R Waddle, Daniel J Ma, Sue L Visscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2019
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma
Daniel J Ma, Katharine A Price, Eric J Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2019
Reply to A.S. Garden
Daniel J Ma, Katharine A Price, Eric J Moore, et al.
Journal for Immunotherapy of Cancer
|
April 15, 2025
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial
Matthew S Block, Garth D Nelson, Jun Chen, et al.
Nature Communications
|
February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Tina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
May 22, 2025
ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial
David M Routman, Kathryn M Van Abel, Katharine A Price, et al.
Oral Oncology
|
September 21, 2023
Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center
Chadi N Abdel-Halim, Thomas J O'Byrne, Jeffrey P Graves, et al.
Oral Oncology
|
May 18, 2025
Identification of clinical and pathologic features associated with extranodal extension in patients with HPV-mediated oropharyngeal squamous cell carcinoma
Brennan Olson, Aaron Bogan, Chadi N Abdel-Halim, et al.
JAMA Network Open
|
May 18, 2026
De-Escalated Adjuvant Radiation Therapy in Patients With HPV-Positive Oropharyngeal Cancer
Cecelia M Hidalgo, Aaron W Bogan, Katelyn S Rourk, et al.
Page
of 15